TRV GP IV, LLC Long-Term Concentrated

CIK: 0001688325 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Aug 10, 2020

Total Value ($000): $217,057 (100.0% shares, 0.0% debt)

Holdings (4)

PLRX PLIANT THERAPEUTICS, INC. 31.9%

Value ($000) $69,233 Shares 2,132,867 Est. Cost $26.54 Unrealized 0.0%

— MAGENTA THERAPEUTICS, INC. 27.7%

Value ($000) $60,142 Shares 8,008,204 Est. Cost $5.70 Unrealized —

RVMD REVOLUTION MEDICINES, INC. 20.7%

Value ($000) $44,826 Shares 1,419,900 Est. Cost $27.68 Unrealized +13.6%

FULC FULCRUM THERAPEUTICS, INC. 19.7%

Value ($000) $42,856 Shares 2,343,154 Est. Cost $11.06 Unrealized +42.3%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PLRX	PLIANT THERAPEUTICS, INC.	2,132,867	$69,233	31.9%	$26.54	0.0%	COM	729139105
—	MAGENTA THERAPEUTICS, INC.	8,008,204	$60,142	27.7%	$5.70	—	COM	55910K108
RVMD	REVOLUTION MEDICINES, INC.	1,419,900	$44,826	20.7%	$27.68	+13.6%	COM	76155X100
FULC	FULCRUM THERAPEUTICS, INC.	2,343,154	$42,856	19.7%	$11.06	+42.3%	COM	359616109